Navigation Links
Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy
Date:12/20/2010

265 students in an intensive four-year Doctor of Pharmacy (Pharm.D.) program. Regional hospitals, health care facilities and practitioners will provide a rich array of experiential sites and employment opportunities," she added.

The School of Pharmacy also has the endorsement of regional hospital, economic development, governmental and higher education leaders who see substantial opportunities to improve health care in Northeast Indiana. "School of Pharmacy faculty and students will be valued citizens of this region, where they will live, shop and volunteer," Switzer said.

The Lilly Endowment grant will significantly assist with startup costs, especially facility and laboratory needs as well as curricular enhancements. It will enable the school to develop the following strengths:

  • A well-equipped, state-of-the-art Fort Wayne facility.
  • A curriculum that educates skilled pharmacists with a commitment to be responsible members of their communities.
  • An outstanding faculty to partner with a strong pharmacy and academic community in the region.
  • Students, faculty and administrators who embrace the distinctive mission of Manchester College.

Perfectly timed in the early stages of the School of Pharmacy launch, the Lilly Endowment grant will enable Manchester College to exceed expectations with enhanced curriculum, specialized experiential sites, state-of-the art educational and research facilities, and institutional capacity, said Philip J. Medon, vice president and founding dean.

Recruiting and hiring are under way for faculty in pharmacy practice, pharmaceutics, medicinal chemistry, pharmacology, pharmacy administration and biomedical science, said Medon, who led the highly successful startup of Southern Illinois University Edwardsville's School of Pharmacy.

"Pharmacists practicing in patient-care environments will comprise the majority of the faculty," Medon
'/>"/>

SOURCE Manchester College
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
2. Manchester Announces Availability of Chenodal(TM)
3. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
4. YouthAIDS, Levis and BETs Rap It-Up Campaign Kick Off 2007 Kick Me Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country
5. Trojan(R) and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health
6. Clinical Impact of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology
7. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
8. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
9. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
10. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
11. Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... its long-term extension to its open label Phase I/II study ... therapy for patients with type 1 Gaucher disease.  The data ... Gaucher Disease (EWGGD) in Cologne, Germany , and add ...
... July 1 Sagent Pharmaceuticals, Inc., a privately ... Food and Drug Administration (FDA) has approved the Company,s ... a vital anticoagulant, preventing the formation of clots and ... in surgical and dialysis settings.  According to IMS, 2009 ...
Cached Medicine Technology:Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 2Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 3Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 4Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 5Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 6FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
(Date:4/18/2014)... The Gerontologist reports that among older ... decrease in anxiety about death and increases in life ... In particular, listening to gospel music is associated with ... in sense of control. , These associations are similar ... of both low- and high-socioeconomic status. , The article, ...
(Date:4/18/2014)... April 18, 2014) Benaroya Research Institute at Virginia ... blocking a particular molecule in metastatic breast cancer reduces ... of lung metastases. BRI scientists have found in models ... tumors by 60 - 80 percent and can keep ... The $1.8 million five-year grant comes from the National ...
(Date:4/18/2014)... Northwestern Medicine scientists could lead to potential new treatments ... with scleroderma. , Fibrosis, or scarring, is a ... skin and lungs can lead to serious organ damage ... new therapeutic options centers on findings made by Swati ... the role that a specific protein plays in promoting ...
(Date:4/17/2014)... new pain relief targets that could be used ... at King,s College London made the discovery when ... periphery of the body. , Dr Marzia Malcangio ... underlying pain generation and our findings could help ... , One potential side effect of some chemotherapy ...
(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2
... The July issue of the health journal Epidemiology has published ... of cancer are higher if there is associated infertility. ... Rockville, Maryland, and her team followed 12,193 U.S. women ... risk among infertile women with that of the general population. ...
... and Drug Administration (FDA) issued a public health advisory to ... marketing of Tysabri (nataluzimab) the drug meant to treat relapsing ... FDA in 2004. , ,FDA supports the decision ... the use of the product in clinical trials. However, it ...
... passive smoking when in the womb of the mother, may ... the study had conducted an 11-year observation of incidence of ... smoking is significantly related to incidence of asthma in childhood. ... contribute towards the incidence of asthma in children. ,Researchers ...
... bypass surgery that is often done as a measure for ... // heart disease. ,One of the most common ... that reduces the size of the stomach and allows the ... with psychological and behavioral support, this procedure has become one ...
... Pharmaceuticals Inc (RPI), they have stated that have ... largest chain store in the US, for outstanding performance ... a global company with more than 1.3 million associates ... 10 countries. , ,RPI is based in Jacksonville, ...
... Scientists have made a new discovery regarding the cells ... , ,Researchers from Wake Forest University School of ... area of the brain can slow the release of ... seizures. Researchers have found that treatment of epilepsy that ...
Cached Medicine News:
... a sterile, nonpyrogenic, viscoelastic preparation of ... weight fraction of sodium hyaluronate., ,Healon ... dissolved in physiological sodium chloride phosphate ... weight polymer is made up of ...
... System is designed to give two viscoelastic ... be used differently and sequentially to perform ... choice of the viscoelastic is based upon ... each to facilitate performance of the surgical ...
... During fiscal year 2004, Biomet ... Navigation System to the global market, ... procedures. The Acumen technology was developed ... private company based in Hollywood, Florida. ...
... in awhile, a product comes along that ... in its category. The new StealthStation TREON ... a product. Built on the phenomenal success ... surgical navigation system in the worldthe new ...
Medicine Products: